Updated Bayesian network meta-analysis on the efficacy and safety of PD-1 versus PD-L1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer.
Saved in:
| Title: | Updated Bayesian network meta-analysis on the efficacy and safety of PD-1 versus PD-L1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer. |
|---|---|
| Authors: | Wang K; Guangzhou University of Chinese Medicine, Guangzhou, China.; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China., Zheng C; Guangzhou University of Chinese Medicine, Guangzhou, China.; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China., Chen X; Guangzhou University of Chinese Medicine, Guangzhou, China.; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China., Lin P; Cancer Center, Departments of Radiation Oncology, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Lin M; Cancer Center, Departments of Radiation Oncology, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Chen C; Cancer Center, Departments of Radiation Oncology, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Zhai L; Cancer Center, Departments of Radiation Oncology, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Jan 28; Vol. 14, pp. 1455306. Date of Electronic Publication: 2025 Jan 28 (Print Publication: 2024). |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39935849 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Updated Bayesian network meta-analysis on the efficacy and safety of PD-1 versus PD-L1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+K%22">Wang K</searchLink>; Guangzhou University of Chinese Medicine, Guangzhou, China.; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zheng+C%22">Zheng C</searchLink>; Guangzhou University of Chinese Medicine, Guangzhou, China.; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Guangzhou University of Chinese Medicine, Guangzhou, China.; Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Lin+P%22">Lin P</searchLink>; Cancer Center, Departments of Radiation Oncology, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Lin+M%22">Lin M</searchLink>; Cancer Center, Departments of Radiation Oncology, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Chen+C%22">Chen C</searchLink>; Cancer Center, Departments of Radiation Oncology, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhai+L%22">Zhai L</searchLink>; Cancer Center, Departments of Radiation Oncology, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Jan 28; Vol. 14, pp. 1455306. <i>Date of Electronic Publication: </i>2025 Jan 28 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Systematic Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39935849 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2024.1455306 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1455306 Titles: – TitleFull: Updated Bayesian network meta-analysis on the efficacy and safety of PD-1 versus PD-L1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang K – PersonEntity: Name: NameFull: Zheng C – PersonEntity: Name: NameFull: Chen X – PersonEntity: Name: NameFull: Lin P – PersonEntity: Name: NameFull: Lin M – PersonEntity: Name: NameFull: Chen C – PersonEntity: Name: NameFull: Zhai L IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 01 Text: 2025 Jan 28 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
